Basic Information
| LncRNA/CircRNA Name | HESRG |
| Synonyms | ESRG, HESRG |
| Region | GRCh38_3:54632122-54639857 |
| Ensemble | ENSG00000265992 |
| Refseq | NR_027122 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | embryonal carcinoma |
| ICD-0-3 | NA |
| Methods | qPCR etc. |
| Sample | central nervous system tumor tissues, cell lines (H1, H9) |
| Expression Pattern | up-regulated |
| Function Description | Our results showed that HESRG was expressed strongly and diffusively in the nuclei of tumor cells in intracranial germinoma and embryonal carcinoma as well as in human embryonic stem cells. These results suggest that HESRG is a novel, sensitive and specific biomarker for intracranial germinoma and embryonal carcinoma. |
| Pubmed ID | 21861197 |
| Year | 2012 |
| Title | HESRG: a novel biomarker for intracranial germinoma and embryonal carcinoma. |
External Links
| Links for HESRG | GenBank HGNC NONCODE |
| Links for embryonal carcinoma | OMIM COSMIC |